PubRank

N Pearce

Author PubWeight™ 234.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995 13.01
2 Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet 1989 5.82
3 Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999 3.87
4 Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002 3.53
5 Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax 1991 3.39
6 Bioaerosol health effects and exposure assessment: progress and prospects. Ann Occup Hyg 2003 3.32
7 Worldwide worsening wheezing--is the cure the cause? Lancet 1992 3.30
8 Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol 1997 3.10
9 The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J 1990 2.61
10 Asthma mortality and inhaled beta agonist therapy. Aust N Z J Med 1991 2.61
11 The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC). Int J Epidemiol 2001 2.27
12 Radiation doses and cause-specific mortality among workers at a nuclear materials fabrication plant. Am J Epidemiol 1988 2.25
13 Prevalence and etiology of asthma. J Allergy Clin Immunol 2000 2.19
14 Passive smoking and passive thinking. N Z Med J 1989 2.17
15 Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997 2.15
16 Beta-agonist therapy and asthma mortality in Japan. Lancet 1998 2.06
17 Baseline risk for asthma deaths. N Z Med J 1992 2.02
18 Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology 1997 1.94
19 Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol 1992 1.92
20 Defining asthma in epidemiological studies. Eur Respir J 1999 1.88
21 Does environmental endotoxin exposure prevent asthma? Thorax 2002 1.88
22 Occupational asthma in New Zealanders: a population based study. Occup Environ Med 1997 1.84
23 Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy 2007 1.81
24 The ecological fallacy strikes back. J Epidemiol Community Health 2000 1.79
25 Latency analysis in occupational epidemiology. Arch Environ Health 1990 1.77
26 Socioeconomic status, asthma and chronic bronchitis in a large community-based study. Eur Respir J 2007 1.64
27 International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax 2000 1.64
28 Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children. Occup Environ Med 2004 1.60
29 Prevalence and risk factors for self-reported asthma in an adult Indian population: a cross-sectional survey. Int J Tuberc Lung Dis 2013 1.57
30 The self reported prevalence of asthma symptoms amongst adult New Zealanders. N Z Med J 1994 1.57
31 Risk factors for asthma symptoms in Kawerau children. N Z Med J 1994 1.56
32 Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy 2009 1.55
33 Asthma in Maori people. N Z Med J 1992 1.54
34 Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med 1992 1.51
35 Case-control study of salmeterol and near-fatal attacks of asthma. Thorax 1998 1.49
36 Environmental epidemiology: challenges and opportunities. Environ Health Perspect 2001 1.47
37 Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group. Eur Respir J 2001 1.46
38 Bladder cancer and occupational exposure to polycyclic aromatic hydrocarbons. Int J Cancer 1989 1.43
39 Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy 1999 1.43
40 Trends in asthma mortality in New Zealand, 1908-1986. Med J Aust 1990 1.41
41 Modes of hepatitis B virus transmission in New Zealand. N Z Med J 1989 1.39
42 Fenoterol and asthma death. N Z Med J 1989 1.39
43 Fenoterol, asthma deaths, and asthma severity: confounding or confusion? Thorax 1997 1.39
44 Asthma deaths in New Zealand. BMJ 1992 1.38
45 Impact of changes in the death registration process upon Maori mortality statistics. N Z Med J 1999 1.38
46 Fenoterol: confounding again. N Z Med J 1989 1.38
47 Inappropriate use of inhaled beta agonists in asthma. N Z Med J 1990 1.37
48 Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers. Environ Health Perspect 1998 1.32
49 How well do questionnaires perform compared with physical examination in detecting flexural eczema? Findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two. Br J Dermatol 2009 1.30
50 A simple computer program for generating person-time data in cohort studies involving time-related factors. Am J Epidemiol 1987 1.27
51 Measuring the prevalence of bronchial hyper-responsiveness in children. Int J Epidemiol 1995 1.24
52 Comparison of a video questionnaire with the IUATLD written questionnaire for measuring asthma prevalence. Clin Exp Allergy 1992 1.23
53 Relationship between fetal growth and the development of asthma and atopy in childhood. Thorax 1999 1.23
54 Chronic bronchitis, work related respiratory symptoms, and pulmonary function in welders in New Zealand. Occup Environ Med 1998 1.19
55 Two year follow up of pulmonary function values among welders in New Zealand. Occup Environ Med 1999 1.18
56 Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J Allergy Clin Immunol 1999 1.18
57 Social class inequalities in the decline of coronary heart disease among New Zealand men, 1975-1977 to 1985-1987. Int J Epidemiol 1991 1.15
58 Adult-onset acute leukemia and employment in the meat industry: a New Zealand case-control study. Cancer Causes Control 2001 1.15
59 Asthma prevalence and deprivation: a small area analysis. J Epidemiol Community Health 1999 1.13
60 Lifelong farm exposure may strongly reduce the risk of asthma in adults. Allergy 2007 1.12
61 Farm exposure in utero may protect against asthma, hay fever and eczema. Eur Respir J 2008 1.11
62 Prevalence of asthma symptoms among adolescents in the Wellington region, by area and ethnicity. N Z Med J 1993 1.10
63 Time-related factors as potential confounders and effect modifiers in studies based on an occupational cohort. Scand J Work Environ Health 1986 1.10
64 Mortality in New Zealand workers exposed to phenoxy herbicides and dioxins. Occup Environ Med 2005 1.10
65 Short- and medium-term results of totally laparoscopic resection for colorectal liver metastases. Br J Surg 2010 1.09
66 Reduced selenium in asthmatic subjects in New Zealand. Thorax 1990 1.09
67 Congenital defects and miscarriages among New Zealand 2, 4, 5-T sprayers. Arch Environ Health 1982 1.07
68 Association of beta2-adrenergic receptor polymorphisms with severe asthma. Clin Exp Allergy 2000 1.07
69 The magnitude of the effect of smaller family sizes on the increase in the prevalence of asthma and hay fever in the United Kingdom and New Zealand. J Allergy Clin Immunol 1999 1.05
70 Occupational risks for brain cancer: a New Zealand Cancer Registry-based study. J Occup Med 1989 1.05
71 Time trends and occupational differences in cancer of the testis in New Zealand. Cancer 1987 1.04
72 Seasonal variation in asthma hospitalizations and death rates in New Zealand. Respirology 2000 1.04
73 Cancer risks in New Zealand farmers. Int J Epidemiol 1989 1.04
74 Health expectancy in New Zealand, 1981-1991: social variations and trends in a period of rapid social and economic change. J Epidemiol Community Health 1999 1.03
75 Is social class standardisation appropriate in occupational studies? J Epidemiol Community Health 1987 1.02
76 Prevalence of respiratory symptoms in migrant children to Italy: the results of SIDRIA-2 study. Allergy 2007 1.02
77 Prescribed drug therapy and near-fatal asthma attacks. Eur Respir J 1994 1.00
78 A comparative study of the efficacy of beclomethasone dipropionate delivered from a breath activated and conventional metered dose inhaler in asthmatic patients. Curr Med Res Opin 1993 1.00
79 Chronic bronchitis, shortness of breath, and airway obstruction by occupation in New Zealand. Am J Respir Crit Care Med 1997 0.99
80 Fenoterol and asthma mortality. Lancet 1989 0.99
81 The relationship between anthropometric measurements at birth: asthma and atopy in childhood. Clin Exp Allergy 1999 0.99
82 Update on methodological issues in the epidemiology of electromagnetic fields and cancer. Epidemiol Rev 1993 0.99
83 Confounding by severity does not explain the association between fenoterol and asthma death. Clin Exp Allergy 1994 0.99
84 Prevalence of adult asthma symptoms in relation to climate in New Zealand. Environ Health Perspect 1998 0.99
85 Problems of measuring asthma prevalence. Respirology 1996 0.99
86 Design and conduct of occupational epidemiology studies: I. Design aspects of cohort studies. Am J Ind Med 1989 0.99
87 Design and conduct of occupational epidemiology studies: II. Analysis of cohort data. Am J Ind Med 1989 0.99
88 The burden of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema in children and adolescents in six New Zealand centres: ISAAC Phase One. N Z Med J 2001 0.99
89 A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol. Eur Respir J 1993 0.98
90 Asthma and other respiratory symptoms in New Zealand pine processing sawmill workers. Am J Ind Med 2001 0.97
91 Occupational physical activity and risk of cancer of the colon and rectum in New Zealand males. Cancer Causes Control 1993 0.96
92 The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma. Clin Pharmacol Ther 1990 0.96
93 Work-related respiratory symptoms in New Zealand farmers. Am J Ind Med 2001 0.95
94 Time-related confounders and intermediate variables. Epidemiology 1992 0.94
95 The international asthma video questionnaire for measuring asthma prevalence in different populations. Int Arch Allergy Immunol 1995 0.94
96 Descriptive epidemiology of primary cancer of the brain, cranial nerves, and cranial meninges in New Zealand, 1948-88. Cancer Causes Control 1993 0.93
97 A study of New Zealand wood workers: exposure to wood dust, respiratory symptoms, and suspected cases of occupational asthma. N Z Med J 1992 0.93
98 Social class differences in mortality from diseases amenable to medical intervention in New Zealand. Int J Epidemiol 1993 0.93
99 Use of near fatal asthma for investigating asthma deaths. Thorax 1993 0.93
100 Trial of a "credit card" asthma self-management plan in a high-risk group of patients with asthma. J Allergy Clin Immunol 1996 0.92
101 Life expectancy as an indicator of outcome in follow-up of population-based cancer registries: the example of childhood leukemia. Ann Oncol 2005 0.92
102 Pathology of asthma and its clinical implications. J Allergy Clin Immunol 1993 0.92
103 Moderate maternal drinking and outcome of pregnancy. Eur J Epidemiol 1993 0.92
104 Classification of asthma severity: should the international guidelines be changed? Clin Exp Allergy 1998 0.92
105 The video questionnaire: one approach to the identification of the asthmatic phenotype. Clin Exp Allergy 1998 0.92
106 Cancer risks in painters: study based on the New Zealand Cancer Registry. Br J Ind Med 1990 0.92
107 He Mate Huango: an update on Maori asthma. Pac Health Dialog 2000 0.91
108 Worker exposures to airborne dust, endotoxin and beta(1,3)-glucan in two New Zealand sawmills. Am J Ind Med 2000 0.90
109 High risk occupations for non-Hodgkin's lymphoma in New Zealand: case-control study. Occup Environ Med 2007 0.90
110 Soft-tissue sarcoma, non-Hodgkin's lymphoma and other cancers in New Zealand forestry workers. Int J Cancer 1989 0.90
111 Occupational respiratory symptoms in New Zealand hairdressers. Occup Med (Lond) 2000 0.90
112 Environmental determinants associated with the development of asthma in childhood. Int J Tuberc Lung Dis 2006 0.90
113 Exposure to magnetic fields among electrical workers in relation to leukemia risk in Los Angeles County. Am J Ind Med 1994 0.90
114 Siblings, asthma, rhinoconjunctivitis and eczema: a worldwide perspective from the International Study of Asthma and Allergies in Childhood. Clin Exp Allergy 2015 0.89
115 Has the role of atopy in the development of asthma been over-emphasized? Pediatr Pulmonol 2001 0.88
116 Asthma and allergy in New Zealand farmers. Am J Ind Med 1999 0.88
117 Lack of evidence for beta-2 receptor selectivity: a study of metaproterenol, fenoterol, isoproterenol, and epinephrine in patients with asthma. Am Rev Respir Dis 1991 0.88
118 Asthma nervosa: old concept, new insights. Eur Respir J 2011 0.88
119 Asthma and having siblings. BMJ 1994 0.87
120 Acute leukemia in electrical workers: a New Zealand case-control study. Cancer Causes Control 2001 0.87
121 Geographical variation in the prevalence of asthma symptoms in New Zealand. N Z Med J 1997 0.87
122 Risk factors for respiratory syncytial virus bronchiolitis hospital admission in New Zealand. Epidemiol Infect 2008 0.86
123 Symptoms suggestive of atopic rhinitis in children aged 6-9 years and the indoor environment. Allergy 2000 0.86
124 The New Zealand Socioeconomic Index: developing and validating an occupationally-derived indicator of socio-economic status. Aust N Z J Public Health 1999 0.86
125 A community trial of a written self management plan for children with asthma. Asthma Foundation of NZ Children's Action. N Z Med J 1996 0.86
126 Respiratory symptoms, across-shift lung function changes and lifetime exposures of welders in New Zealand. Scand J Work Environ Health 1997 0.85
127 Determinants of house dust mite allergen in homes in Wellington, New Zealand. Clin Exp Allergy 1997 0.85
128 Risk factors for symptoms of childhood asthma, allergic rhinoconjunctivitis and eczema in the Pacific: an ISAAC Phase III study. Int J Tuberc Lung Dis 2008 0.85
129 Mortality and cancer incidence in New Zealand meat workers. Occup Environ Med 2004 0.85
130 The effect of season-of-response to ISAAC questions about asthma, rhinitis and eczema in children. Int J Epidemiol 1997 0.85
131 Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study. Ann Oncol 2007 0.85
132 Comparison of reported prevalences of recent asthma in longitudinal and cross-sectional studies. Eur Respir J 1997 0.85
133 Asthma and the beta agonist debate. Thorax 1995 0.85
134 The decline in asthma hospitalisations in persons aged 0-34 years in New Zealand. Aust N Z J Med 1997 0.84
135 A case-control study of risk factors for asthma in New Zealand children. Aust N Z J Public Health 2001 0.84
136 Using directed acyclic graphs to consider adjustment for socioeconomic status in occupational cancer studies. J Epidemiol Community Health 2008 0.84
137 Aetiological, predisposing and environmental factors in dentine hypersensitivity. Arch Oral Biol 1994 0.84
138 Cardiovascular effects of fenoterol under conditions of hypoxaemia. Thorax 1992 0.84
139 Is testicular cancer an occupational disease of fire fighters? Am J Ind Med 2001 0.83
140 International trends in asthma mortality. Ciba Found Symp 1997 0.83
141 Phenoxy herbicides and non-Hodgkin's lymphoma in New Zealand: frequency and duration of herbicide use. Br J Ind Med 1989 0.83
142 House dust mite allergen levels in public places in New Zealand. J Allergy Clin Immunol 1997 0.83
143 Beta-agonists and death from asthma. N Engl J Med 1992 0.83
144 A philosophy for dealing with hypothesized uncontrolled confounding in epidemiological investigations. Med Lav 1995 0.83
145 Long-term reduction in asthma morbidity following an asthma self-management programme. Eur Respir J 1998 0.83
146 Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic. Int Arch Allergy Immunol 1995 0.83
147 The prevalence of asthma symptoms, bronchial hyperresponsiveness and atopy in New Zealand adults. N Z Med J 1999 0.83
148 Respiratory symptoms and environmental factors in schoolchildren in the Bay of Plenty. N Z Med J 1995 0.83
149 Selenium, glutathione peroxidase and asthma. Clin Exp Allergy 1991 0.82
150 Albuterol and deaths from asthma in New Zealand from 1969 to 1976: a case-control study. Clin Pharmacol Ther 1992 0.82
151 The ideal minister of (public) health. J Epidemiol Community Health 2002 0.81
152 Control selection with incomplete case ascertainment. Am J Epidemiol 1988 0.81
153 Asthma prevalence in adults: good news? Thorax 2004 0.81
154 A New Zealand Cancer Registry-based study of cancer in wood workers. Cancer 1989 0.81
155 Fenoterol, asthma deaths, and asthma severity. Chest 1997 0.81
156 Time trends and seasonal patterns of asthma deaths and hospitalisations among Maori and non-Maori. N Z Med J 2002 0.81
157 Insulin in bile. The effect of monosaccharides and hypoglycaemic agents. Diabetologia 1969 0.81
158 ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme. J Med Chem 1996 0.81
159 Very-low-dose hepatitis B vaccine in newborn infants: an economic option for control in endemic areas. Lancet 1987 0.81
160 Prevalence of symptoms of childhood asthma, allergic rhinoconjunctivitis and eczema in the Pacific: the International Study of Asthma and Allergies in Childhood (ISAAC). Allergy 2007 0.81
161 SR-12813 lowers plasma cholesterol in beagle dogs by decreasing cholesterol biosynthesis. Atherosclerosis 1997 0.81
162 A review of the studies of the asthma mortality epidemic in New Zealand. Allergy Proc 1995 0.81
163 Reduction in asthma morbidity following a community-based asthma self-management programme in Tonga. Int J Tuberc Lung Dis 2009 0.80
164 Asthma in New Zealand: myths and realities. N Z Med J 2000 0.80
165 Occupational exposure to carcinogens in developing countries. IARC Sci Publ 1994 0.79
166 Ethnic differences in time trends in asthma prevalence in New Zealand: ISAAC Phases I and III. Int J Tuberc Lung Dis 2009 0.79
167 Is enhanced fetal growth a risk factor for the development of atopy or asthma? Int Arch Allergy Immunol 1999 0.79
168 Indoor environment, atopy and the risk of the asthma in children in New Zealand. Pediatr Allergy Immunol 1999 0.79
169 Beta-agonist use and death from asthma. JAMA 1994 0.79
170 Association of non-Hodgkin's lymphoma with rheumatoid arthritis. Am J Med 1986 0.78
171 ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo. J Med Chem 1998 0.78
172 Stomach cancer in New Zealand: time trends, ethnic group differences and a cancer registry-based case-control study. Int J Epidemiol 1991 0.78
173 End of New Zealand asthma epidemic. Lancet 1995 0.77
174 Occupational bladder cancer in New Zealand: a 1-year review of cases notified to the New Zealand Cancer Registry. Intern Med J 2005 0.77
175 The prevalence and demographic distribution of treated epilepsy: a community-based study in Tasmania, Australia. Acta Neurol Scand 2011 0.77
176 Consumption of unpasteurized milk and its effects on atopy and asthma in children and adult inhabitants in rural Poland. Allergy 2013 0.77
177 Aluminium in the drinking water--is it safe? Aust J Public Health 1991 0.77
178 Preclinical studies of monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer. Cell Biophys 1994 0.76
179 Illumination of x-rays: the usual lights exposed. Postgrad Med J 2003 0.75
180 Beta 2-agonists and New Zealand asthma mortality. Lancet 1991 0.75
181 Fenoterol prescribing and asthma severity. N Z Med J 1990 0.75
182 Asthma mortality. N Z Med J 1985 0.75
183 Bronchial responsiveness during regular fenoterol therapy. N Z Med J 1991 0.75
184 Smoking and financial health. N Z Med J 1989 0.75
185 Fenoterol and asthma mortality. N Z Med J 1990 0.75
186 Time trends in fenoterol and asthma deaths: optical illusion or reality check? J Clin Epidemiol 1998 0.75
187 Cold comfort for carers. BMJ 1992 0.75
188 Asthma severity and fenoterol prescribing. N Z Med J 1991 0.75
189 Re: "Confounding by indication and channeling over time: the risks of beta2-agonists". Am J Epidemiol 1997 0.75
190 Asthma morbidity and mortality in New Zealand. Thorax 1995 0.75
191 Bronchial reactions to exposure to welding fumes. Occup Environ Med 1998 0.75
192 Fenoterol: enough is enough. N Z Med J 1992 0.75
193 Research in fire prevention. Hosp Eng 1985 0.75
194 New Zealand trends in acute rheumatic fever and chronic rheumatic heart disease 1971-1981. N Z Med J 1984 0.75
195 Cancer. IARC Sci Publ 1994 0.75
196 Bile acid synthesis in hamster hepatocytes in primary culture: sources of cholesterol and comparison with other species. Biochim Biophys Acta 1993 0.75
197 Characteristics of ovarian cancer in women residing in Aotearoa, New Zealand: 1993-2004. J Epidemiol Community Health 2009 0.75
198 Unemployment and the public health. N Z Med J 1990 0.75
199 Mini-Wright Peak Flow Meter. N Z Med J 1982 0.75
200 Beta agonists and asthma. N Z Med J 1990 0.75
201 Passive smoking in New Zealand. N Z Med J 1989 0.75
202 Computer predictions of New Zealand doctor numbers. N Z Med J 1982 0.75
203 Changes in work practice after a respiratory health survey among welders in New Zealand. N Z Med J 2000 0.75
204 Autumn Books: Clambering to incompetence over a mountain of corpses. Br Med J (Clin Res Ed) 1987 0.75
205 Respiratory questionnaire responses: how they change with time. N Z Med J 1997 0.75
206 Slit-lamp photography of the eye. Med Biol Illus 1974 0.75
207 Electromagnetic fields and cancer: an ongoing debate. N Z Med J 1991 0.75
208 Goal planning, needs assessment & advocacy. Health Serv Manage 1993 0.75
209 Cervical cancer in Pacific Island Polynesians. N Z Med J 1989 0.75
210 Postoperative pyomyositis following total hip replacement--a case report. J R Coll Surg Edinb 1995 0.75
211 The mini-Wright peak flow meter. N Z Med J 1983 0.75
212 Asthma in Pacificans in New Zealand and in the South Pacific. Pac Health Dialog 2001 0.75
213 The New Zealand asthma mortality epidemic. Clin Sci (Lond) 1995 0.75
214 Immunogenicity of low doses of hepatitis B vaccine in children: a study in 650 New Zealand children. J Med Virol 1987 0.75
215 The cost of cigarette smoking. N Z Med J 1988 0.75
216 Incidence of hepatocellular carcinoma in New Zealand, 1974-78: ethnic, sex and geographical differences. N Z Med J 1985 0.75
217 Monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer. Cell Biophys 1995 0.75
218 Under the volcano: fire, ash and asthma? N Z Med J 1997 0.75
219 Epidemiological studies on genetic polymorphism: study design issues and measures of occurrence and association. IARC Sci Publ 1999 0.75
220 Pine dust, atopy and lung function: A cross-sectional study in sawmill workers. Eur Respir J 2006 0.75
221 Fenoterol and fear of flying. N Z Med J 1989 0.75
222 Low-dose vaccination against hepatitis B in children: one-year follow-up. J Med Virol 1987 0.75
223 A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol. N Z Med J 1990 0.75